Latest Adaptive Biotechnologies Corporation Stories
SEATTLE, April 28, 2015 /PRNewswire/ -- Adaptive Biotechnologies today announced the recent publication of a study conducted with researchers at The University of Texas MD Anderson Cancer Center
SEATTLE, April 22, 2015 /PRNewswire/ -- Adaptive Biotechnologies today announced the recent publication of a study demonstrating that analysis of circulating tumor DNA (ctDNA) using the company's
SEATTLE, April 15, 2015 /PRNewswire/ -- Adaptive Biotechnologies, the company pioneering Next Generation Sequencing (NGS) applications for cancer immunology, and its collaborators will present
SEATTLE, March 17, 2015 /PRNewswire/ -- Adaptive Biotechnologies Corporation, the pioneer in leveraging next generation sequencing to profile T-cell and B-cell receptors, today announced that members
SEATTLE, March 3, 2015 /PRNewswire/ -- Adaptive Biotechnologies announced today that Chad Cohen, Zillow Group CFO, is joining its Board of Director as Chair of the Audit Committee.
Deal Expected to Expedite the Development and Commercialization of Immunosequencing Applications SEATTLE, Jan.
Data Validates Clinical Advantage of Tracking Minimal Residual Disease with the clonoSEQ(TM) Test in Patients with ALL, CLL, MM, DLBCL SEATTLE, Dec.
immunoSEQ(TM) Next Generation Sequencing Assay Confirms Presence of Active Immune Response in Responders Prior to Treatment SEATTLE, Nov.
First available immunosequencing Kit with validated bias control methodology to ensure data reliability SEATTLE, Nov.
- A woman chauffeur.
- A woman who operates an automobile.